Company signals · Biotech & Pharma
Valion Bio
1 signal in the current window, with MitchelLake's leadership read on each.
Last updated
Market context: The wider read — a Talent Market Index of 95.4 (Cool), down 5.3 month-on-month — shows Americas signal flow easing (-16.2pts).
Valion Bio: 1 signal in the last 90 days — in line with the Biotech & Pharma median of 1 across 31 tracked companies.
Signals at Valion Bio
Executive hires, departures and board changes at Valion Bio
Every leadership-change and senior-hiring signal observed at Valion Bio, newest first, each dated and linked to the source record.
Valion Bio signals in the last 90 days
1 public signal observed since 22 August 2026, by type.
More signals across Biotech & Pharma
Leadership Change · Americas
Vir Biotechnology →Vir Biotechnology (Nasdaq: VIR) appointed Johns Hopkins cancer immunotherapy expert Suzanne Topalian, M.D., to its Board of Directors, effective October 27, 2026.
Leadership Change · Americas
Valion Bio Inc. →Valion Bio names Thomas H. Jensen, CEO of Allarity Therapeutics, as board chair to advance Entolimod program for acute radiation syndrome following company transformation
Leadership Change · Americas
Flagship Pioneering →Flagship Pioneering, a scientific innovation engine, appointed two Executive Partners: Fidah Alsagoff (Head of Global Initiatives) and Maggie Sahlman (Head of Fundraising and Investor Relations).
Leadership Change · Americas
Teva Pharmaceuticals →Teva Pharmaceuticals CEO Richard Francis discusses Q2 earnings, drug pipeline, and the company's direct listing on NYSE. Signals leadership visibility and capital market transition.
Product Launch · Americas
ABEC →ABEC announced the commercial launch of the ATB-2100 Advanced Therapy Bioreactor, a single-use cell expansion platform aimed at advanced therapy (cell and gene therapy) manufacturing.
Partnership · Americas
Boehringer Ingelheim →Endpoints News teaser references a collaboration between Boehringer Ingelheim and Microsoft. The excerpt is truncated and gives no terms, scope or deal size.
Where Valion Bio's market lands in our work
- Board Search & Advisory →
Incoming executives reshape governance needs within two quarters.
- Private Equity →
Listed and PE-backed boards renew leadership against a value-creation clock.
- Executive Search: Americas →
Our Americas practice runs the searches behind signals like this one.
Intelligence powered by Autonodal ↗
Nearby in the record
- Data period
- 23 Sept 2026 – 23 Sept 2026 · 1 signals for this company
- Methodology
- How this is computed
- Publisher
- MitchelLake
Last updated
